The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine.
We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes (plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks.
All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities. The two tracks are intertwined and presentations from the two tracks en bloc provide a complete picture of the liquid biopsy space as it currently exists.
Present Your Research at this Conference in a Poster to a Worldwide Audience. Poster Submission Deadline: November 2, 2015.